Consolidated Statements Of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2023
OPERATING ACTIVITIES:
Net Income (Loss)	$ 20,154	$ 10,528	$ 14,778
Adjustments to reconcile net income to net cash provided by (used in) operating activities:
Depreciation	3,654	3,997	4,572
Deferred income taxes	(3,837)	(1,454)	(7,154)
Stock-based compensation expense	3,869	4,647	3,191
Change in provision for losses on accounts receivable	(244)	(160)	(380)
Right-of-use asset impairment	14,079
(Gain) on disposition of property, plant and equipment	(9,446)	(2,839)	(313)
Changes in operating assets and liabilities:
Trade receivables	9,253	(5,910)	3,318
Inventories	7,441	25,499	19,136
Other current assets	(962)	(1,681)	(1,467)
Other assets	(7,586)	(6,518)	(3,865)
Accounts payable - trade	(579)	1,373	(7,320)
Accrued liabilities	830	4,177	(1,270)
Other long-term liabilities	353	224	(237)
Net cash provided by operating activities	36,979	31,883	22,989
INVESTING ACTIVITIES:
Proceeds from sales of investments	1,155
Proceeds from sales of property, plant and equipment	11,535	4,179	340
Capital expenditures	(3,258)	(4,772)	(4,790)
Net cash provided by (used in) investing activities	9,432	(593)	(4,450)
FINANCING ACTIVITIES:
Dividends paid	(3,556)	(3,219)	(3,241)
Treasury stock purchases		(1,659)	(3,700)
Proceeds from lines of credit	202,344	367,818	363,805
Payments on lines of credit	(207,262)	(391,270)	(373,271)
Proceeds from issuance of common stock	141	88
Shares withheld for tax payments on vested shares and options exercised	(2,833)	(1,652)	(951)
Net cash (used in) financing activities	(11,166)	(29,894)	(17,358)
Increase in cash and cash equivalents	35,245	1,396	1,181
Cash and cash equivalents at beginning of year	4,761	3,365	2,184
Cash and cash equivalents at end of year	40,006	4,761	3,365
SUPPLEMENTAL INFORMATION
Interest paid	107	1,694	1,069
Interest received	421
Cash paid for income taxes, net	9,397	4,296	4,104
Capital expenditures in accounts payable	$ 390	$ 23	$ 311